인슐린 펌프 시장 규모, 점유율 및 성장 분석 : 유형별, 구성부품별, 질환별, 치료법별, 용도별, 환자층별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Insulin Pump Market size was valued at USD 6.05 Billion in 2024 and is poised to grow from USD 6.55 Billion in 2025 to USD 12.32 Billion by 2033, growing at a CAGR of 8.22% during the forecast period (2026-2033).

The global market for insulin pumps is experiencing significant expansion, driven by an increasing prevalence of diabetes, notably type 1 diabetes, along with a heightened awareness of effective management options. As more individuals seek portable insulin delivery solutions, the industry has adapted to meet evolving consumer needs. Key contributors to this growth include advancements in technology, such as the integration of artificial intelligence and machine learning into insulin pumps, enhancing their functionality and efficiency. Rising healthcare expenditures and improved access to medical resources have further fueled market demand. With diabetes linked to serious complications, there is a pressing need for innovative insulin delivery systems, making the insulin pump market a critical area within the broader healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pump Market Segments Analysis

Global Insulin Pumps Market is segmented by Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel and region. Based on Type, the market is segmented into Tethered Insulin Pumps, Patch Pumps (Tubeless Pumps), Miniature/Implantable Pumps and Smart Insulin Pumps. Based on Component, the market is segmented into Pump Device, Infusion Set (Cannula & Tubing), Reservoir or Cartridge, Battery and Power Systems and Control System & Software. Based on Disease Indication, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on Type of Therapy, the market is segmented into Conventional Insulin Therapy, Continuous Subcutaneous Insulin Infusion (CSII), Automated Insulin Delivery (AID) or Closed Loop Systems and Hybrid Closed Loop Systems. Based on Usage Type, the market is segmented into Reusable Insulin Pumps and Disposable Insulin Pumps. Based on Patient Demographics, the market is segmented into Pediatric (0-17 years), Adult (18+ years) and Geriatric (65+ years). Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Direct Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Pump Market

The Global Insulin Pump market is witnessing significant growth driven by key players focusing on research and development of innovative technologies and the introduction of new products. This surge is largely attributed to the increasing adoption of insulin pumps by diabetic patients in both developed and emerging markets. Additionally, numerous clinical trials demonstrate the effectiveness of pump therapy in enhancing glucose control for type 2 diabetes patients compared to those utilizing Multiple Daily Injection (MDI) therapy. These advancements in technology and improvements in patient outcomes are propelling the market forward, creating new opportunities for stakeholders in the industry.

Restraints in the Global Insulin Pump Market

A significant challenge facing the global insulin pump market is the reliance of numerous patients on reimbursement options to afford necessary treatments for their conditions. The limited availability of reimbursement and the high expenses associated with insulin pumps discourage many individuals from utilizing this technology. This financial barrier presents an obstacle to broader adoption, potentially hindering the growth and development of the insulin pump market on a global scale. As affordability remains a crucial factor in healthcare access, the struggle to secure adequate reimbursement options may impact the willingness of patients to invest in insulin pumps for their management needs.

Market Trends of the Global Insulin Pump Market

The Global Insulin Pump market is experiencing a dynamic transformation fueled by the integration of intelligent technologies, particularly artificial intelligence, into diabetes management solutions. As the prevalence of type 2 diabetes continues to rise globally, there is an escalating demand for sophisticated insulin delivery systems that offer enhanced automation and personalization. Medical device manufacturers are poised to leverage this trend, developing AI-enabled pumps that streamline glucose monitoring and insulin delivery. This increasing reliance on advanced technologies is projected to significantly boost the adoption rates of insulin pumps, reflecting a broader shift towards more efficient and effective diabetes care solutions in the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment
• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment

Global Insulin Pump Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Insulin Pumps
  • Tethered Pumps
  • Patch Pumps
  • Smart Insulin Pumps
  • Others
• Consumables & Accessories
  • Infusion Sets
  • Reservoirs/Cartridges
  • Others

Global Insulin Pump Market Size by Disease Indication & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Pump Market Size by Therapy Type & CAGR (2026-2033)

• Market Overview
• Conventional Therapy
• Continuous Insulin Infusion
• Automated Insulin Delivery
• Hybrid Closed Loop Systems

Global Insulin Pump Market Size by Usage Type & CAGR (2026-2033)

• Market Overview
• Reusable Pumps
• Disposable Pumps

Global Insulin Pump Market Size by Patient Demographics & CAGR (2026-2033)

• Market Overview
• Pediatric (0-17 Years)
• Adult (18+ Years)
• Geriatric (65+ Years)

Global Insulin Pump Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Homecare
• Laboratories

Global Insulin Pump Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Direct Sales

Global Insulin Pump Market Size & CAGR (2026-2033)

• North America (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Disease Indication, Therapy Type, Usage Type, Patient Demographics, End Use, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sooil Development Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beta Bionics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellnovo Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViCentra B.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Delfu Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Debiotech S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtrum Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTech Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sequel Med Tech, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaSens
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Menarini Diagnostics

• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
• Bayer Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eversense (Senseonics)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations